Abstract
Sorafenib alone versus a combination of sorafenib and ninjin'yoeito for the treatment of patients with advanced hepatocellular carcinoma: a retrospective study and pharmacological study in rats
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
